Lincluden Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.22M | Sell |
58,371
-42,506
| -42% | -$2.3M | 0.34% | 55 |
|
|
2025
Q4 | $3.53M | Buy |
100,877
+39,397
| +64% | +$1.84M | 0.3% | 55 |
|
|
2025
Q3 | $2.65M | Sell |
61,480
-540
| -0.9% | -$21.1K | 0.3% | 61 |
|
|
2025
Q2 | $2.38M | Sell |
62,020
-4,108
| -6% | -$157K | 0.26% | 63 |
|
|
2025
Q1 | $2.24M | Hold |
66,128
| – | – | 0.28% | 61 |
|
|
2024
Q4 | $2.24M | Buy |
66,128
+127
| +0.2% | +$4.57K | 0.27% | 63 |
|
|
2024
Q3 | $2.7M | Buy |
66,001
+833
| +1% | +$34.1K | 0.29% | 61 |
|
|
2024
Q2 | $2.51M | Sell |
65,168
-84
| -0.1% | -$3.53K | 0.3% | 64 |
|
|
2024
Q1 | $2.8M | Sell |
65,252
-723
| -1% | -$29.8K | 0.33% | 58 |
|
|
2023
Q4 | $2.44M | Sell |
65,975
-103,772
| -61% | -$3.73M | 0.3% | 60 |
|
|
2023
Q3 | $6.15M | Sell |
169,747
-1,131
| -0.7% | -$40.1K | 0.74% | 25 |
|
|
2023
Q2 | $6.09M | Buy |
170,878
+78
| +0% | +$2.8K | 0.7% | 30 |
|
|
2023
Q1 | $6.08M | Buy |
170,800
+164
| +0.1% | +$5.74K | 0.69% | 30 |
|
|
2022
Q4 | $6M | Buy |
+170,636
| New | +$5.68M | 0.7% | 30 |
|
|
2022
Q3 | – | Sell |
-155,334
| Closed | -$8.45M | – | 70 |
|
|
2022
Q2 | $8.45M | Sell |
155,334
-2,557
| -2% | -$141K | 0.92% | 22 |
|
|
2022
Q1 | $8.6M | Sell |
157,891
-908
| -0.6% | -$49.3K | 0.76% | 26 |
|
|
2021
Q4 | $8.75M | Sell |
158,799
-1,219
| -0.8% | -$63.4K | 0.8% | 26 |
|
|
2021
Q3 | $7.64M | Sell |
160,018
-4,430
| -3% | -$223K | 0.77% | 27 |
|
|
2021
Q2 | $8.19M | Sell |
164,448
-1,622
| -1% | -$77.9K | 0.79% | 26 |
|
|
2021
Q1 | $7.41M | Buy |
166,070
+14,892
| +10% | +$676K | 0.72% | 26 |
|
|
2020
Q4 | $6.95M | Buy |
151,178
+9,928
| +7% | +$456K | 0.72% | 27 |
|
|
2020
Q3 | $6.65M | Sell |
141,250
-4,712
| -3% | -$236K | 0.66% | 26 |
|
|
2020
Q2 | $7.44M | Sell |
145,962
-7,432
| -5% | -$381K | 0.78% | 24 |
|
|
2020
Q1 | $7.26M | Buy |
153,394
+13,144
| +9% | +$701K | 0.88% | 22 |
|
|
2019
Q4 | $8.24M | Sell |
140,250
-1,966
| -1% | -$109K | 0.74% | 21 |
|
|
2019
Q3 | $7.59M | Sell |
142,216
-188
| -0.1% | -$9.67K | 0.7% | 20 |
|
|
2019
Q2 | $7.12K | Sell |
142,404
-8,256
| -5% | -$414K | 0.45% | 20 |
|
|
2019
Q1 | $7.87M | Sell |
150,660
-40,516
| -21% | -$2.02M | 0.75% | 21 |
|
|
2018
Q4 | $9.13M | Sell |
191,176
-6,624
| -3% | -$326K | 0.7% | 19 |
|
|
2018
Q3 | $9.93M | Sell |
197,800
-26,348
| -12% | -$1.34M | 0.83% | 26 |
|
|
2018
Q2 | $11.3M | Sell |
224,148
-2,696
| -1% | -$136K | 0.82% | 26 |
|
|
2018
Q1 | $11.1M | Buy |
226,844
+7,068
| +3% | +$329K | 0.89% | 25 |
|
|
2017
Q4 | $9.74M | Buy |
219,776
+49,888
| +29% | +$2.3M | 0.68% | 35 |
|
|
2017
Q3 | $8.62M | Buy |
169,888
+76,320
| +82% | +$3.87M | 0.67% | 33 |
|
|
2017
Q2 | $5.04M | Sell |
93,568
-3,108
| -3% | -$166K | 0.43% | 40 |
|
|
2017
Q1 | $5.09M | Buy |
96,676
+1,592
| +2% | +$80.8K | 0.46% | 42 |
|
|
2016
Q4 | $4.58M | Sell |
95,084
-12,661
| -12% | -$625K | 0.5% | 43 |
|
|
2016
Q3 | $5.81M | Buy |
107,745
+11,652
| +12% | +$639K | 0.85% | 37 |
|
|
2016
Q2 | $5.21M | Buy |
96,093
+9,633
| +11% | +$507K | 0.86% | 39 |
|
|
2016
Q1 | $4.38M | Buy |
86,460
+2,668
| +3% | +$133K | 0.74% | 42 |
|
|
2015
Q4 | $4.23M | Sell |
83,792
-56,852
| -40% | -$2.9M | 0.86% | 39 |
|
|
2015
Q3 | $6.76M | Buy |
140,644
+88,084
| +168% | +$4.59M | 1.31% | 27 |
|
|
2015
Q2 | $2.74K | Sell |
52,560
-15,588
| -23% | -$878K | 0.34% | 52 |
|
|
2015
Q1 | $3.93M | Sell |
68,148
-968
| -1% | -$55.5K | 0.56% | 47 |
|
|
2014
Q4 | $3.69M | Buy |
69,116
+3,900
| +6% | +$218K | 0.36% | 50 |
|
|
2014
Q3 | $3.75M | Buy |
65,216
+1,436
| +2% | +$88K | 0.36% | 56 |
|
|
2014
Q2 | $4.26M | Buy |
63,780
+7,412
| +13% | +$502K | 0.39% | 55 |
|
|
2014
Q1 | $3.77M | Buy |
56,368
+5,084
| +10% | +$344K | 0.35% | 55 |
|
|
2013
Q4 | $3.42M | Sell |
51,284
-6,876
| -12% | -$446K | 0.31% | 53 |
|
|
2013
Q3 | $3.65M | Sell |
58,160
-5,236
| -8% | -$337K | 0.46% | 49 |
|
|
2013
Q2 | $3.96K | Buy |
+63,396
| New | +$4.02M | 0.01% | 49 |
|
Other funds holding GSK
JEST
Lincluden Management's GSK Position: Q1 2026 in Review
Lincluden Management reduced its GSK (GSK) stake by 42% in Q1 2026, selling an estimated $2.3M and leaving 58,371 shares worth $3.22M. The position accounts for 0.34% of the portfolio, ranked #55.
Lincluden Management first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $11.3M in Q2 2018. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Lincluden Management held 58,371 shares of GSK worth $3.22M as of Q1 2026.
- Lincluden Management sold 42,506 GSK shares in Q1 2026, an estimated $2.3M.
- GSK made up 0.34% of Lincluden Management's portfolio in Q1 2026, its #55 holding.
- Lincluden Management first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
- Lincluden Management's GSK position peaked at $11.3M in Q2 2018.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Lincluden Management's 13F filing for Q1 2026, filed 13 May 2026.